Archived Publications

2016

  1. Interaction Of The Dye Congo Red With Fibrils Of Lysozyme, Beta2-Microglobulin And Transthyretin
    Antimonova O.I., Grudinina N.A., Egorov V.V., Polyakov D.S., Iljin V.V., Shavlovsky M.M.*
    Cell and Tissue Biology. – 2016. – Volume 10, Issue 6, pp 468–475
    DOI / PMC Abstract
  2. Biological evaluation of tetracationic compounds based on two 1,4-diazabicyclo[2.2.2]octane moieties connected by different linker
    Burakova E.A., Saranina I.V., Tikunova N.V., Nazarkina Z.K., Laktionov P.P., Karpinskaya L.A., Anikin V.B., Zarubaev V.V., Silnikov V.N.*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 22, PP. 6012–6020
    DOI / PMC Abstract
  3. Characterization of oligomerization of a peptide from the ebola virus glycoprotein by small-angle neutron scattering
    Egorov V.V., Gorshkov A.N., Murugova T.N., Vasin A.V., Lebedev D.V., Isaev-Ivanov V.V., Kiselev O.I.*
    Crystallography Reports. – 2016. – Volume 61, Issue 1, pp 94–97
    DOI / PMC Abstract
  4. On the structural features of influenza A nucleoprotein particles from small-angle X-ray scattering data
    Egorov V.V., Shaldzhyan A.A., Gorshkov A.N.,  Zabrodskaya Ya.A., Lebedev D.V., Kuklin A.I., Ksenofontova O.I., Shvetsov A.V. , Vasin A.V. et al*
    Journal of Surface Investigation. – 2016. – Volume 10, Issue 2, pp 322-325
    DOI / PMC Abstract
  5. Virus-inhibiting activity of dihydroquercetin, a flavonoid from Larix sibirica, against coxsackievirus B4 in a model of viral pancreatitis
    Galochkina A.V., Anikin V.B., Babkin V.A., Ostrouhova L.A., Zarubaev V.V.*
    Archives of Virology. – 2016. – Volume 161, Issue 4, pp 929–938
    DOI / PMC Abstract
  6. Functional linkage between the transport characteristics of the MDCK1 cell monolayer and their actin cytoskeleton organization
    Gorshkov A.N., Zaitseva M.R., Snigirevskaya E.S., Komissarchik Ya.Yu.*
    Cell and Tissue Biology. – 2016. – Volume 10, Issue 2, pp 133–144
    DOI / PMC Abstract
  7. Modeling of conformational transitions of fibrillogenic peptide, homologous to beta-domain of human alpha-lactalbumin
    Kadochnikov V.V. Egorov V.V., Shvetsov A.V., Kuklin A.I., Isaev-Ivanov V.V., Lebedev D.V.*
    Crystallography Reports. – 2016. – Volume 61, Issue 1, pp 98–105
    DOI / PMC Abstract
  8. Model System for Multifunctionaldelivery Nanoplatforms Based On-Polymer Complexes Containing Silver Nanoparticles and Fluorescent Dye
    Kasyanenko N., Bakulev V., Perevyazko I., Nekrasova T., Nazarova O., Zolotova Y., Panarin E., Slita A.*
    Journal of Biotechnology. – 2016. – Volume 236, Pages 78–87
    DOI / PMC Abstract
  9. Rapid spread of influenza A(H1N1)pdm09 viruses with a new set of specific mutations in the internal genes in the beginning of 2015/2016 epidemic season in Moscow and Saint-Petersburg (Russian Federation)
    Komissarov A., Fadeev A., Petrov S., Sergeeva M., Sintsova K., Egorova A., Pisareva M., Buzitskaya Z., Musaeva T., Danilenko D., Konovalova N., Petrova P., Stolyarov K., Smorodintseva E., Burtseva E., Krasnoslobodtsev K., Kirillova E., Karpova L., Eropkin M., Sominina A., Grudinin M.*
    Influenza and Other Respiratory Viruses. – 2016. – Volume 10, Issue 4, Pages 247–253
    DOI / PMC Abstract
  10. Genetic characterization of influenza viruses from influenza-related hospital admissions in the St. Petersburg and Valencia sites of the Global Influenza Hospital Surveillance Network during the 2013/14 influenza season
    López-Labrador FX, Natividad-Sancho A, Pisareva M, Komissarov A, Salvatierra K, Fadeev A, Moya A, Grudinin M, Díez-Domingo J, Afanasieva O, Konovalova N, Sominina A, Puig-Barberà J.*
    Journal of Clinical Virology. – 2016. – Volume 84, November 2016, Pages 32–38
    DOI / PMC Abstract
  11. High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin
    Mardanova ES, Kotlyarov RY, Kuprianov VV, Stepanova LA, Tsybalova LM, Lomonossoff GP, Ravin NV*
    Bioengineered. – 2016. – Volume 7, Issue 1, pp 28–32
    DOI / PMC Abstract
  12. Designing anti-influenza vaccines in line with the population’s genetic profile
    Onishchenko G.G., Kiselev O.I.*
    Herald of the Russian Academy of Sciences. – 2016. – Vol. 86. № 3. pp 197-205
    DOI / PMC Abstract
  13. Anti-influenza activity of monoterpene-derived substituted hexahydro-2H-chromenes
    Patrusheva OS, Zarubaev VV, Shtro AA, Orshanskaya YR, Boldyrev SA, Korchagina DV, Volcho KP, Salakhutdinov NF*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 21, Pages 5158–5161
    DOI / PMC Abstract
  14. Development of a multiplex quantitative PCR assay for the analysis of human cytokine gene expression in influenza A virus-infected cells
    Plotnikova M.A., Klotchenko S.A., Vasin A.V.
    Journal of Immunological Methods. – 2016. – Volume 430, Pages 51–55
    DOI / PMC Abstract
  15. Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the global influenza hospital surveillance network
    Puig-Barberà J., Burtseva E., Yu H., Cowling B.J., Badur S., Kyncl J., Sominina A., Afanasieva O., Afanasieva V., Ciblak M.A., Aktas F., Belenguer-Varea Á., Borekci S., Boza F., Buzitskaya Z., Caetano B., Cai J., Çakir B., Carballido-Fernández M. et al.*
    BMC Public Health. – 2016. – Volume 16, (Suppl 1):757
    DOI / PMC Abstract
  16. Epidemiology of hospital admissions with influenza during the 2013/2014 northern hemisphere influenza season: results from the global influenza hospital surveillance network
    Puig-Barberà J., Natividad-Sancho A., Mira-Iglesias A., López-Labrador X., Trushakova S., Kisteneva L., Burtseva E., Garina E., Kolobukhina L., Krasnoslobotsev K., Merkulova L., Mukasheva E., Vartanyan R., Sominina A., Pisareva M., Stolyarov K., Afanasieva V., Buzitskaya Z., Fadeev A., Smorodintseva E. et al.*
    PLoS ONE. – 2016. – May 19;11(5):e0154970
    DOI / PMC Abstract
  17. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Rudenko L., Isakova-Sivak I., Naykhin A.,  Kiseleva I., Stukova M.,  Erofeeva M.,  Korenkov D., Matyushenko V., Sparrow E., Kieny M.P.*
    The Lancet Infectious Diseases. – 2016. – Volume 16, Issue 3, Pages 303–310
    DOI / PMC Abstract
  18. Derivatives of usnic acid inhibit broad range of influenza viruses and protect mice from lethal influenza infection
    Shtro A.A., Zarubaev V.V., Luzina O.A., Sokolov D.N., Salakhutdinov N.F.*
    Antiviral Chemistry and Chemotherapy. – 2016. – vol. 24, 3-4: pp. 92-98
    DOI / PMC Abstract
  19. Efficiency of Canephron N in complex treatment of experimental heymann glomerulonephritis
    Sivak K.V., Lesiovskaya E.E., Stosman K.I., Savateeva-Lubimova T.N.*
    Clinical Phytoscience. – 2016. – Volume 2, Issue 1
    DOI / PMC Abstract
  20. Adenosine A2A receptor as a drug target for treatment of sepsis
    Sivak KV, Vasin AV, Egorov VV, Tsevtkov VB, Kuzmich NN, Savina VA, Kiselev OI*
    Molecular Biology. – 2016. – Volume 50, Issue 2, pp 200–212
    DOI / PMC Abstract
  21. Aliphatic and alicyclic camphor imines as effective inhibitors of influenza virus H1N1
    Sokolova AS, Yarovaya I, Shernyukov V, Baev DS, Shtro AA, Zarubaev VV, Salakhutdinov NF*
    European Journal of Medicinal Chemistry. – 2016. – Available online 19 October 2016, In Press
    DOI / PMC Abstract
  22. Influence of single amino acid substitutions in the hemagglutinin on the antigenic and receptor-binding properties of influenza virus B/Florida/04/2006 of Yamagata-like evolutionary lineage
    Sorokin Evgeniy V., Tsareva Tatyana R., Sominina Anna A., Pisareva Maria M., Komissarov Andrey B., Kosheleva nna .
    Microbiology Independent Research Journal . – 2016. – Volume 3, Number 1, pp 56-60
    DOI / PMC Abstract
  23. A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity
    Stepanova L.A., M. V. Sergeeva, M. A. Shuklina, A. A. Shaldzhyan, M. V. Potapchuk, A. V. Korotkov, L. M. Tsybalova
    Acta Naturae. – 2016. – Vol. 8, № 2(29)
    DOI / PMC Abstract
  24. Interaction between cationic agents and small interfering RNA and DNA molecules
    Unksov I.N., Slita A.V., Petrova A.V., Pereviazko I., Bakulev V.M., Rolich V.I., Bondarenko A.B., Kasyanenko N.A.*
    Journal of Physics: Conference Series. – 2016. – Volume 769, Number 1
    DOI / PMC Abstract
  25. The influenza A virus NS genome segment displays lineage-specific patterns in predicted RNA secondary structure
    Vasin A.V., Petrova A.V., Egorov V.V., Plotnikova M.A., Klotchenko S.A., Karpenko M.N., Kiselev O.I.*
    BMC Research Notes. – 2016. – (9):(279)
    DOI / PMC Abstract
  26. Tautomeric and non-tautomeric N-substituted 2-iminobenzimidazolines as new lead compounds for the design of anti-influenza drugs: an in vitro study
    Zarubaev VV., Morkovnik AS, Divaeva LN, Karpinskaya LA, Borodkin GS*
    Bioorganic & Medicinal Chemistry. – 2016. – Volume 24, Issue 22, Pages 5796–5803
    DOI / PMC Abstract
  27. Main Aetiological Features of Acute Respiratory Viral Diseases in Young People of Draft Age and Conscripts During the 2013-2014 Epidemic Season
    Zhdanov K., Lvov N., Maltsev O., Peredelsky E. and Pisareva M.*
    International Review of the Armed Forces Medical Services. – 2016. – V. 89/2. - 58-63
    DOI / PMC Abstract

2015

  1. Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents
    Kiselev O.I., Vasin A.V., Deeva E.G., Sivak K.V., Egorov V.V., Tsvetkov V.B., Egorov A.Y., Romanovskaya-Romanko E.A., Stepanova L.A., Komissarov A.B., Tsybalova L.M., Ignatjev G.M., Shevyryova M.P.*
    Molecular Biology [Moscow].  – 2015. – Vol.49, № 4. – P. 480-493. [English version]
  2. Peptide-induced amyloid conformational transitions in proteins
    Egorov  V., Grudinina  N., Vasin A., Lebedev D.
    International Journal of Peptides. – 9/2015 (2015). Article ID 723186, 5 pp.
  3. Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray
    Heydarov R.N., Fesenko E.E., Shaskolskiy B.L., Titov S.V., Dementieva E.I., Zasedatelev A.S., Mikhailovich V.M., Klotchenko S.A., Vasin A.V., Kiselev O.I.*
    Doklady. Biochemistry and Biophysics. – 2015. – Vol.460, № 1. – P. 4-8. [English version]
    Epub 2015 Mar 13.
    doi: 10.1134/S1607672915010032.
  4. Nucleophilic substitution of nitro group in nitrotriazolotriazines as a model of potential interaction with cysteine-containing proteins
    Rusinov V.L., Sapozhnikova I.M., Ulomskii E.N., Medvedeva N.R., Egorov V.V., Kiselev O.I., Deeva E.G., Vasin A.V., Chupakhin O.N.*
    Chemistry of Heterocyclic Compounds. – 2015. – Vol. 51, Issue 3. – P.275–280. [English version]
    Epub 2015 Apr 16.
  5. Regulatory role of small nucleolar RNAs in human diseases
    Stepanov G.A., Filippova J.A., Kuligina E.V., Richter V.A., Semenov D.V., Komissarov A.B., Tang T.H.*
    Biomed Research International. – 2015. – ID 206849, 10 pp.
  6. Synthesis  and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments
    Matusevich O.V., Egorov V.V., Gluzdikov I.A., Titov M.I., Zarubaev V.V., Shtro A.A., Slita A.V., Dukov M.I., Shurygina A.-P., Smirnova T.D., Kudryavtsev I.V., Vasin A.V., Kiselev O.I.*
    Antiviral Research. – 2015. – Vol. 113. – P.4-10.
    doi: 10.1016/j.antiviral.2014.10.015. Epub 2014 Nov 12.
  7. Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo
    Zarubaev V.V., Garshinina A.V., Tretiak T.S., Fedorova V.A., Shtro A.A., Sokolova A.S., Yarovaya O.I., Salakhutdinov N.F.
    Antiviral Research. – 2015. – Vol. 120. – P.126-133.
    doi: 10.1016/j.antiviral.2015.06.004. Epub 2015 Jun 10.
  8. Discovery of a new class of antiviral compounds: Camphor imine derivatives
    Sokolova A.S. , Yarovaya O.I., Shernyukov A.V., Gatilov Y.V., Razumova Y.V., Zarubaev V.V.,  Tretiak T.S.,  Pokrovsky A.G., Kiselev O.I., Salakhutdinov N.F.*
    European Journal of Medical Chemistry. – 2015. – Vol.105. – P.263-273.
    doi: 10.1016/j.ejmech.2015.10.010. Epub 2015 Oct 22.
  9. Glycyrrhizic acid derivatives as influenza A/H1N1 virus inhibitors
    Baltina L.A. Jr., Zarubaev V.V., Baltina L.A., Orshanskaya I.A., Fairushina A.I., Kiselev O.I., Yunusov M.S.*
    Bioorganic & Medicinal Chemistry Letters. – 2015. – Vol. 25, № 8. – P.1742-1746.
    doi: 10.1016/j.bmcl.2015.02.074. Epub 2015 Mar 7.
  10. Synthesis and antiviral activity of quercetin brominated derivatives
    Karimova E., Baltina L., Spirikhin L., Gabbasov T., Orshanskaya Y., Zarubaev V.
    Natural Product Communications. – 2015.Vol. 10, № 9. – P.1565-1568.
  11. New  carbocyclic N6-substituted adenine and pyrimidine nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; synthesis, antiviral, anticancer activity and X-ray crystallography
    Tănase C.I., Drăghici C., Cojocaru A., Galochkina A.V., Orshanskaya J.R., Zarubaev V.V., Shova S., Enache C., Maganu M.*
    Bioorganic & Medicinal Chemistry. – 2015. – Vol. 23, № 19. – P.6346-6354.
    doi: 10.1016/j.bmc.2015.08.033. Epub 2015 Sep 1.
  12. Search for antiviral agents among quinopimaric acid scaffold derivatives
    Vafina G.F.,  Uzbekov A.R., Zarubaev V.V., Karpinskaya L.A., Shtro A. A., Yunusov M.S.
    Chemistry of Natural Compounds. – 2015. – Vol.51, № 1. – P.103-107. [English version]
  13. Activity of Thermopsis schischkinii alkaloids against influenza A(H1N1)pdm09 virus
    Tsypysheva I.P., Galkin E.G., Baikova I.P., Fedorov N.I., Petrova P.R.,.Orshanskaya Ya.R., Fedorova V.A., Zarubaev V.V.
    Chemistry of Natural Compounds. – 2015. – Vol.51, № 5. – P.1003-1005.
    Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin
    Stepanova L.A., Kotlyarov R.Y., Kovaleva A.A., Potapchuk M.V., Korotkov A.V., Sergeeva M.V., Kasianenko M.A., Kuprianov V.V., Ravin N.V., Tsybalova L.M., Skryabin K.G., Kiselev O.I.*
    PLoS One. – 2015. – Vol. 10, № 3. – e0119520.
    doi: 10.1371/journal.pone.0119520
  14. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors
    Mardanova E.S., Kotlyarov R.Y., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Lomonosoff G.P., Ravin N.V.
    BMC Biotechnology. – 2015. – Vol. 15. – 42.
    doi: 10.1186/s12896-015-0164-6.
  15. High immunogenicity of plant-produced influenza based on the M2e peptide fused to flagellin
    Mardanova E.S., Kotlyarov R.Y., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Lomonosoff G.P., Ravin N.V.*
    Bioengineered. – 2015. – Dec 28:0. [Epub ahead of print]
    doi: 10.1186/s12896-015-0164-6.
  16. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective efficiency
    Ravin N.V., Blokhina E.A., Kuprianov V.V., Stepanova L.A., Shaldjan A.A., Kovaleva A.A., Tsybalova L.M., Skryabin K.G.*
    Vaccine. – 2015. – Vol. 33, № 29. - P. 3392–3397.
    doi: 10.1016/j.vaccine.2015.04.066. Epub 2015 Apr 29.
  17. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e
    Tsybalova L.M., Stepanova L.A., Kuprianov V.V., Blokhina E.A., Potapchuk M.V., Korotkov A.V., Gorshkov A.N., Kasyanenko M.A., Ravin N.V., Kiselev O.I.*
    Vaccine. – 2015. – Vol. 33, № 29. - P. 3398–3406.
    doi: 10.1016/j.vaccine.2015.04.073. Epub 2015 May 11.
  18. Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double- blind phase 1 study
    Rudenko L., Kiseleva I., Stukova M.,  Erofeeva M.,  Naykhin A.,  Donina S.,  Larionova N., Pisareva M., Krivitskaya V., Flores J.; Russian LAIV Trial Study group*
    Vaccine. – 2015. – Vol. 33, № 39. – P.5110-5117. -
    doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.
  19. Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses
    Kiseleva I., Dubrovina I.,  Fedorova E., Larionova N., Isakova-Sivak I., Bazhenova E., Pisareva M., Kuznetsova V., Flores J., Rudenko L.*
    Vaccine. – 2015. – Vol. 33, № 49. – P.7008-7014.
    doi: 10.1016/j.vaccine.2015.09.050. Epub 2015 Oct 2.
  20. H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
    Isakova-Sivak I., Stukova M.,  Erofeeva M.,  Naykhin A.,  Donina S.,  Petukhova G.,  Kuznetsova V.,  Kiseleva I.,  Smolonogina T., Dubrovina I.,  Pisareva M.,  Nikiforova A.,  Power M., Flores J., Rudenko L.*
    Human Vaccines & Immunotherapeutics. – 2015. – Vol. 11, № 4. – P.970- 982. -
    doi: 10.1080/21645515.2015.1010859.
  21. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
    Rudenko L., Naykhin A.,  Donina S.,  Korenkov D., Petukhova G.,  Isakova-Sivak I., Losev I., Stukova M.,  Erofeeva M.,  Nikiforova A.,  Power M., Flores J.*
    Human Vaccines & Immunotherapeutics. – 2015. – Vol. 11, № 12. – P.2839-2848.
    doi: 10.1080/21645515.2015.1069931.
  22. H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Rudenko L., Isakova- Sivak I., Naykhin A.,  Kiseleva I., Stukova M.,  Erofeeva M.,  Korenkov D., Matyushenko V., Sparrow E., Kieny M.P.*
    The Lancet. Infectious Diseases. – 2015. – Dec. 7. Pii: S1473-3099 (15)00378-3.
    doi: 10.1016/S1473-3099(15)00378-3. [Epub ahead of print].
  23. A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice
    Kittel C., Wressnigg N., Shurygina A.P., Wolschek M., Stukova M.,  Romanovskaya-Romanko E., Romanova J., Kiselev O., Muster T., Egorov A.
    Archives of Virology.2015. – Vol. 160, № 10. – P.2525- 2534.
    doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28.
  24. Mutations in human genes that increase the risk for severe influenza infection
    Kiselev O. I., Komissarov A. B., Konshina O.S , Dmitrieva M.N., Deyeva E.G., Sologub T.V., Pokrovskiy V.I.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
  25. Changes in the antigenic and genetic structure of influenza viruses: analysis of surveillance data of influenza A and B in Russia in 2006-2013
    Grudinin M.P., Pisareva M.M., Komissarov A.B., Kosheleva A.A., Buzitskaya J.V., Stukova M.A., Prokopetz A.V., Danilenko D.M., Konovalova N.I., Lobova T.G., Sominina A.A., Kiselev O.I.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
  26. Two years of experience in hospital surveillance for the severe influenza like illnesses in St. Petersburg: etiology, clinical characterization of diseases, antigenic and genetic properties of isolated influenza viruses
    Sominina A.A., Pisareva M. M., Grudinin M.P., Eropkin M.Yu., Konovalova N.I, Sukhovetskaya V.F., Afanasieva O.I., Voloshuk L.V., Komissarov A.B., Buzitskaya Z.V., Fadeev A.V., Stolyarov K.A., Smorodintseva E.A., Afanasieva V.S., Yanina M.A., Gonchar V.V., Osidak L.V., Go A.A.
    MIRJournal (Microbiology Independent Research Journal). – 2015. – Vol.2, № 1.
  27. The Global Influenza Hospital Surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza
    Puig- Barberà  J., Tormos A.,Trushakova  S., Sominina  A., Pisareva M. et al.
    Influenza and Other Respiratory Viruses. – 2015.  – Vol. 9, Issue 6. – P.277–286.
    doi: 10.1111/irv.12335
  28. Surveillance for severe acute respiratory infections (SARI) in hospitals in the WHO European region – an exploratory analysis of risk factors for a severe outcome in influenza-positive SARI cases
    Meerhoff T.J., Simaku A, Ulqinaku D, Torosyan L, Gribkova N, Shimanovich V, Chakhunashvili G, Karseladze I, Yesmagambetova A, Kuatbayeva A, Nurmatov Z, Otorbaeva D, Lupulescu E, Popovici O, Smorodintseva E, Sominina A, Holubka O, Onyshchenko O, Brown CS, Gross D.*
    BMC Infectious Diseases. – 2015. – Vol. 15. – 1.
    doi: 10.1186/s12879- 014-0722-x.
  29. Nanosolutions
    Lyubchik S., Lyubchik A., Makarova T., Eropkin M.
    International Innovation. – 2015. – Issue 187. - P. 31-33.
  30. Physicochemical molecular, and biological properties of complexes formed between aminoglycoside antibiotics and some anionic copolymers of acrylic series: Part II
    Tarabukina E.B., Solovskii M.V., Pautov V.D., Amirova A.I., Zahkarova N.V., Smirnova M.Y., Anan’eva T.D., Imanbaev R.T., Eropkin M.Y., Eropkina E.M.*
    Journal of Bioactive and Compatible Polymers: Biomedical Applications. – 2015. – Vol.30, № 6. – P.571-583.
    Epub July 6, 2015 doi:10.1177/0883911515592258.

Books and proceedings:

Abstracts of the 18th Annual Meeting of European Society for Clinical Virology, 9th–12th September 2015, Edinburgh // Journal of Clinical Virology. – Vol.70, Suppl.1.

  • Effect of single amino acid substitutions in the hemagglutinin on the receptor-binding properties of influenza B viruses
    Sorokin E., Tsareva T., Sominina A., Pisareva M., Komissarov A., Kosheleva A. – P.S29 (Abstr. № 1502).
  • Influenza in Russia in the season 2014–2015: Epidemiology and antigenic properties of viruses
    Eropkin M., Karpova. L., Konovalova N., Lobova T., Petrova P., Eropkina E., Schekanova S., Sominina A. – P.S30 (Abstr. № 1503).
  • Virus etiology of SARI cases and protective role of influenza vaccination determined in sentinel surveillance system
    Smorodintseva E., Sominina A., Stolyarov K., Sysoeva T. – P.S30 (Abstr. № 1504).

2014

Research papers:

  1. Molecular mechanisms enhancing the proteome of influenza A viruses: An overview of recently discovered proteins
    Vasin A.V., Temkina O.A.,  Egorov V.V., Klotchenko S.A., Plotnikova M.A., Kiselev O.I.
    Virus Research. – 2014. – Vol. 185. – P.53-63.
    doi: 10.1016/j.virusres.2014.03.015. Epub 2014 Mar 24.
  2. Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector
    Kuznetsova I., Shurygina A.P., Wolf B., Wolschek M., Enzmann F., Sansyzbay A., Khairullin B., Sandybayev N., Stukova M., Kiselev O., Egorov A., Bergmann M.*
    Journal of General Virology. – 2014. – Vol.95, pt.2. – P.337-349.
    doi: 10.1099/vir.0.056036-0. Epub 2013 Nov.12.
  3. A conservative mutant of a proteolytic fragment produced during fibril formation enhances fibrillogenesis
    Egorov V.V., Lebedev D.V., Shaldzhyan A.A., Sirotkin A.K., Gorshkov A.N., Mirgorodskaya O.A., Grudinina N.A., Vasin A.V., Shavlovsky M.M. *
    Prion. – 2014. – Vol.8, 5. – P.369-373.
    doi: 10.4161/19336896.2014.983745.
  4. Comparative evaluation of effectiveness of IAVchip DNA microarray in influenza A diagnosis
    Sultankulova K.T., Chervyakova O.V., Kozhabergenov N.S., Shorayeva K.A., Strochkov V.M., Orynbaev M.B., Sandybayev N.T., Sansyzbay A.R., Vasin A.V.*
    Scientific World Journal. – 2014. – (2014). – ID 620580. – 11 pp.
    doi: 10.1155/2014/620580. Epub 2014 Nov.23.
  5. The use of inducers of apoptosis in treatment of experimental influenza infection and prevention of chronic postinfluenza lung lesions
    Zarubaev V. V., Tribulovich V. G., Belyaevskaya S. V.,  Barlev N.A.*
    Cell and Tissue Biology. – 2014. – Vol.8, Issue 4. – P.344-351.
    (Original version: Tsitologiya. – 2014. – Vol.56, 3. – P.241-247.)
  6. Camphor-based symmetric diimines as inhibitors of influenza virus reproduction
    Sokolova A.S. , Yarovaya O.I., Korchagina D.V.,  Zarubaev V.V.,  Tretiak T.S.,  Anfimov P.M. , Kiselev O.I., Salakhutdinov N.F. *
    Bioorganic and Medical Chemistry. – 2014. – Vol.22, Issue 7. – P.2141-2148.
    doi: 10.1016/j.bmc.2014.02.038. Epub 2014 Mar 1.
  7. Novel derivatives of usnic acid effectively inhibiting reproduction of influenza A virus
    Shtro A.A., Zarubaev V.V., Luzina O.A., Sokolov D.N., Kiselev O.I., Salakhutdinov N.F.*
    Bioorganic and Medical Chemistry. – 2014. – Vol.22, Issue 24. – P.6826-6836.
    doi: 10.1016/j.bmc.2014.10.033. Epub 2014 Oct 31.
  8. Synthesis and antiviral activity of bis-spirocyclic derivatives of rhodanine
    Kurbatov S.V., Zarubaev V.V., Karpinskaya L.A., Shvets A.A., Kletsky M.E., Burov O.N., Morozov P.G., Kiselev O.I., Minkin V.I. *
    Russian Chemical Bulletin. – 2014. – Vol.63, Issue 5. – P.1130-1136.
    (Original version: Izvestiya Akademii Nauk.Ser. Khimicheskaya – 2014. – 5. – P.1130-1136.)
  9. New amino-acid conjugates of glycyrrhizic acid
    Baltina L.A. Jr., Stolyarova O.V., Baltina L.A., Kondratenko R.M., Fedorova V.A., Orshanskaya Ya.A., Zarubaev V.V.*
    Chemistry of Natural Compounds. – 2014. – Vol.50, Issue 2. – P.317-320.
  10. Synthesis and antiviral activity of amino-acid conjugates of glycyrrhetic acid
    Baltina L.A. Jr., Khudobko M.V., Mikhailova L.R., Baltina L.A., Fedorova V.A., Orshanskaya Ya.A., Zarubaev V.V., Kiselev O.I.*
    Chemistry of Natural Compounds. – 2014. – Vol.50, Issue 3. – P.473-477.
  11. Porous silicon and its applications in biology and medicine
    Ksenofontova O. I., Vasin A.V., Egorov V.V., Kiselev. O.I., Bobyl A.V., Soldatenkov F.Yu., Terukov E.I., Ulin V.P., Ulin N.V.*
    Technical Physics. The Russian Journal of Applied Physics.  – 2014. – Vol. 59, Issue 1. – P. 66-77.
    (Original version: Zhurnal Tekhnicheskoi Fiziki, – 2014. – Vol.84, 1. – P.67-78.)
  12. Photodynamic inactivation of enveloped virus in protein plasma preparations by solid-phase fullerene-based photosensitizer
    Belousova I.M.,  Kislyakov I.M., Muraviova T.D., Starodubtsev A.M., Kris’ko T.K. , Selivanov E.A. , Sivakova N.P., Golovanova I.S., Volkova S.D., Shtro A.A.,  Zarubaev V.V. *
    Photodiagnosis and Photodynamic Therapy. –  2014. – Vol.11, Issue 2. – P.165-170.
    doi:10.1016/j.pdpdt.2014.02.009
  13. Recombinant strain A/HK/Otar/6:2/2010 (H3N8) for development of a live intranasal equine influenza vaccine
    Chervyakova O.V., Strochkov V.M., Tailakova E.T., Sultankulova K.T., Sandybayev N.T., Sansyzbay A.R., Gorev N.A., Sergeeva M.V., Potapchuk M.V., Repko I.A., Tsybalova L.M., Kiselev O.I.*
    Journal of Equine Veterinary Science. – 2014. – Vol.34, Issue 6. – P.749-758.
  14. Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo–controlled, randomized double–blind phase I study of live attenuated H7N3 influenza vaccine
    Rudenko L., Kiseleva I., Naykhin A., Erofeeva M., Stukova M., Donina S., Petukhova G., Pisareva M., Krivitskaya V., Grudinin M., Buzitskaya Zh., Isakova-Sivak I., Kuznetsova S., Larionova N.,  Desheva J., Dubrovina I., Nikiforova A., Victor J., Neuzil K., Flores J., Tsvetnitsky V., Kiselev O.*
    PLoS One. – 2014. – Vol. 9, 2. – e87962.
    doi: 10.1371/journal.pone.0087962
  15. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network
    Puig-Barberà J., Natividad-Sancho A., Launay O., Burtseva E., Ciblak M.A.,  Tormos A., Buigues-Vila A., Martinez-Ubeda S., Sominina A.; GIHSN Group*
    PLoS One. – 2014. – Vol. 9, 6. – e100497. (Correction: PLoS One. – 2014. – Vol. 9, 9. – e107849.)
    doi: 10.1371/journal.pone.0100497.
  16. Evidence of specialized tissue in human interatrial septum: histological, immunohistochemical and ultrastructural findings
    Mitrofanova L.B., Gorshkov A.N., Lebedev D.S., Mikhaylov E.N.*
    PLoS One. – 2014. – Vol. 9, 11. – e113343.
    doi: 10.1371/journal.pone.0113343.
  17. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season
    Puig-Barberà J., Tormos A.,  Sominina A., Burtseva E., Launay O., Ciblak M.A., Natividad-Sancho A., Buigues-Vila A., Martinez-Ubeda S., Mahe C.; GIHSN Group*
    BMC Public Health. – 2014. – Vol. 14. – 564.
    doi: 10.1186/1471-2458-14-564.
  18. Vitreous films of Ga6Ge17S43 composition as a biochip substrate
    Vasil’eva A.S., Borisov E.N., Klotchenko S.A., Tver’yanovich A.S., Tver’yanovich Yu.S.*
    Glass Physics and Chemistry. – 2014. – Vol.40, Issue 4. – P.467-469.
    (Original version: Fizika i Khimiya Stekla. – 2014. – Vol.40, 4. – P.615-618.)
  19. As39S6 films as protein-selective two-dimensional arrays for biochips
    Vasil’eva A.S., Belykh A.V., Klotchenko S.A., Tver’yanovich A.S., Tver’yanovich Yu.S.*
    Glass Physics and Chemistry. – 2014. – Vol.40, Issue 4. – P.470-471.
    (Original version: Fizika i Khimiya Stekla. – 2014. – Vol.40, 4. – P.619-621.)
  20. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines
    Nakowitsch S., Waltenberger A.M., Wressnigg N., Ferstl N., Triendl A., Kiefmann B., Montomoli E., Lapini G., Sergeeva M.,  Muster T., Romanova J.R.
    Biotechnology Journal. – 2014. – Vol.9, Issue 3. – P. 405-414.

Books and proceedings:

The Fifth ESWI Influenza Conference, Riga, Latvia, September 14–17, 2014:

  • Comparative Analysis of MariPOC System And RRT-PCR in Detection of Influenza a Virus in Clinical Samples
    Petrova, Ekateria; Krivitskaya, Vera; Pisareva, Maria; Buzitskaya, Zhanna; Sukhovetskaya, Vera; Danilenko, Daria; Suddenkova, Polina; Sominina, Anna A.
    SPA1P06
  • Epitope Mapping of the Hemagglutinin Molecule of Influenza B/Yamagata And B/Victoria Lineage Viruses Using Monoclonal Antibodies
    Sorokin, Evgenii; Tsareva, Tatiana; Sominina, Anna A.; Pisareva, Maria; Komissarov, Andrei; Kosheleva, Anna
    SPB5P08
  • Host-specific Distribution of (+)-RNA Secondary Structures in Segment 8 of Influenza A Viruses
    Vasin, Andrey; Petrova, Alexandra; Plotnikova, Marina; Klotchenko, Sergey; Egorov, Vladimir; Kiselev, Oleg
    SPB5P02
  • Influenza Epidemic Season 2013-2014 in Russia: Characteristics of Isolated Strains
    Eropkin, Mikhail; Danilenko, Daria; Konovalova, Nadejda; Komissarov, Andrey; Pisareva, Maria; Grudinin, Mikhail; Lobova, Tamara; Schekanova, Svetlana; Kornilova, Ekaterina; Eropkina, Elena; Suddenkova, Polina
    SPA2P04
  • Some Approaches to Prediction of Seasonal Influenza Epidemic Burden
    Sominina, Anna A.; Karpova, Ludmila; Smorodintseva, Elizaveta; Grudinin, Mikhail; Pisareva, Maria; Komissarov, Andrei; Eropkin, Mikhail; Konovalova, Nadejda; Danilenko, Daria
    SPA2P12
  • Molecular Peculiarities of Influenza A and B Viruses Circulating in Russia During Two Epidemic Seasons in 2012-2014
    Komissarov, Andrey; Kosheleva, Anna; Fadeev, Artem; Elpaeva, Ekaterina; Mikhailova, Maria; Pisareva, Maria; Buzitskaya, Janna; Stukova, Marina; Danilenko, Daria; Konovalova, Nadejda; Eropkin, Mikhail; Grudinin, Mikhail
    SPB5P05
  • Hospitalizations with Influenza in the Northern Hemisphere 2013-2014 Influenza Season. Results from the Global Influenza Hospital Surveillance Network
    Puig-Barberà, Joan; Tormos, Anita Marie Catherine; Sominina, Anna; Ciblak, Meral; Mira-Iglesias, Ainara; Natividad-Sancho, Angels; Buigues-Vila, Amparo; Burtseva, Elena
    SPA1P03

4th International Influenza Meeting, Muenster, Germany, September 21–23, 2014:

  • Infection of primary endometrium cells with influenza A(3N2) virus can cause their functional dysregulation
    Danilenko D.M., Smirnova T.D., Pisareva M.M., Durnova A.O., Kadirova R.A., Smirnova S.S.*
    Abstr.P15. – P.62.
  • Antiviral and cytoprotective activity of Influcid® in cell cultures model systems
    Eropkin M., Eropkina E., Bryazhikova T.
    Abstr.P23. – P.70.
  • Influenza surveillance in swine in North-Western region of Russia
    Komissarov A.B., Konovalova N.I., Fadeev A.V., Sintsova K.S., Palaziuk S.V., Aliev A.S., Danilenko D.M., Eropkin M.Yu., Grudinin M.P.*
    Abstr.P51. – P.98.
  • A new aspect of influenza virus pathogenesis
    Azarenok A.A., Prochukhanova A.R., Ilynskaya E.V., Zenin V.V., Lublinskaya O.G., Eropkina E.M., Zhilinskaya I.N.
    Abstr.P74. – P.121.
  • Immunogenicity graphs as a method of assessment and comparison of viruses in the contemporary influenza vaccine
    Voytsehovskaya E.M., Vasilyeva A.A., Kuznetsova E.V., Vakin V.S., Sominina A.A.
    Abstr.P108. – P.155.

17th Annual Meeting of the European Society for Clinical Virology (ESCV), Prague, Czech Republic, September 27–October 1, 2014:

  • A novel automated mariPOC® detection test detects well current and emerging inluenza A virus subtypes
    Koskinen J., Sominina A.A., Krivitskaya V. Z., Voycekhovskaya E.V., Toivola H., Koskinen J.O.*
    Abstr.P01. – ID 63.

2013

Research papers:

  1. Influenza surveillance in Russia based on epidemiological and laboratory data for the period from 2005 to 2012
    Sominina A., Burtseva E., Eropkin M., Karpova L., Zarubaev V., Smorodintseva E., Konovalova N., Danilenko D., Prokopetz A., Grudinin M., Pisareva M., Anfimov P., Stolyarov K., Kiselev O., Shevchenko E., Ivanova V., Trushakova S., Breslav N., Lvov D., Klimov A., Moen A., Cox N. *
    American Journal of Infectious Diseases. – 2013. – Vol.9, № 3. – P.77-93
  2. Transmission studies resume for avian flu
    Fouchier R.A., Garcia-Sastre A., Kawaoka Y., …… Kiselev O.I., et al.*
    Science. – 2013. – Vol.339, № 6119. – P.520-521.
    doi: 10.1126/science.1235140. Epub 2013 Jun 23.
  3. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution
    Koel B.F., Burke D.F., Bestebroer T.M., ………. Eropkin M.Y., et al.*
    Science. – 2013. – Vol.342, № 6161. – P.976-979.
    doi: 10.1126/science.1244730. Epub 2013 Jun 23.
    Structural features of the peptide homologous to 6-25 fragment of influenza A PB1 Protein
    Egorov V.V., Matusevich O.V., Shaldzhyan A.A., Skvortsov A.N., Zabrodskaya Ya.A., Garmay Yu.P., Landa S.B., Lebedev D.V., Zarubayev V.V., Sirotkin A.K., Vasin A.V., Kiselev O.I. *
    International Journal of Peptides. – 2013. – Vol. 2013. – ID 370832. – 5 pp. http://dx.doi.org/10.1155/2013/370832
  4. Amyloidogenic peptide homologous to fragment 129-148 of human myocilin
    Egorov V.V., Grudinina N.A., Lebedev D.V., Shaldzhyan A.A., Slita A.V., Sirotkin A.K., Vasin A.V., Shavlovsky M.M.*
    Prion. – 2013. – Vol. 7, № 3. – P.248-252.
    doi: 10.4161/pri.24239.
  5. Magnetic labeling of proteins for atomic force microscopy
    Egorov V.V., Zabrodskaya Y.A., Kalinin A.S., Lebedev D.V., Grudinina N.A., Vasin A.V., Kolikov V.A., Klotchenko S.A., Shawlovsky M.M., Rutberg P.G. *
    Doklady. Biochemistry and Biophysics. – 2013. – Vol.448, Issue 1. – P.33-35.
    doi: 10.1134/S1607672913010080. Epub 2013 Mar 13.
    (Original version: Doklady Akademii Nauk. – 2013. – Vol.448, № 4. – P.477-479.)
  6. An inactivated adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans
    Sansyzbay A.R., Erofeeva M.K., Khairullin B.M., Sandybaev N.T., Kydyrbaev Z.K., Mamadaliyev  S.M., Kassenov M.M., Sergeeva M.V., Romanova J.R., Krivitskaya V.Z., Kiselev O.I., Stukova M.A. *
    Clinical and Vaccine Immunology. – 2013. – Vol.20, № 8. – P.1314-1319.
    doi: 10.1128/CVI.00096. Epub 2013 Jun 26.
  7. The use of transient expression systems for the rapid production of virus-like particles in plants
    Thuenemann E.C., Lenzi P., Love A.J., Taliansky M., Bécares M., Zuñiga S., Enjuanes L., Zahmanova G.G., Minkov I.N., Matić S., Noris E., Meyers A., Hattingh A., Rybicki E.P., Kiselev O.I., Ravin N.V.*
    Current Pharmaceutical Design. – 2013. – Vol.19, Issue 31. – P.5564-5573. [Review.]
  8. Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by tobacco mosaic virus-based vectors
    Petukhova N.V., Gasanova T.V., Stepanova L.A., Rusova O.A., Potapchuk M.V., Korotkov A.V., Skurat E.V., Tsybalova L.M., Kiselev O.I., Ivanov P.A., Atabekov J.G.*
    Current Pharmaceutical Design. – 2013. – Vol.19, Issue 31. – P.5587-5600. doi:10.2174/13816128113199990337
  9. Study of immunogenicity of recombinant proteins based on hemagglutinin and neuraminidase conservative epitopes of influenza A virus
    Dukhovlinov I., Al-Shekhadat R., Fedorova E., Stepanova L., Potapchuk M., Repko I., Rusova O., Orlov A., Tsybalova L., Kiselev O.
    Medical Science Monitor Basic Research. – 2013. – Vol.19. – P.221-227.
    doi:10.12659/MSMBR.884002
  10. Synthesis of new compounds combining adamantanamine and monoterpene fragments and their antiviral activity against influenza virus A(H1N1)pdm09
    Teplov G.V., Suslov E.V., Zarubaev V.V., Shtro A.A., Karpinskaya L.A., Rogachev A.D., Korchagina D.V.,
    Volcho K.P., Salakhutdinov N.F., Kiselev O.I.*
    Letters in Drug Design & Discovery. – 2013. – Vol. 10, № 6. –  P.477-485.
  11. New quaternary ammonium camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity
    Sokolova A.S., Yarovaya C.O., Shernyukov C.A., Pokrovsky C.E., Pokrovsky C.A., Lavrinenko V.A., Zarubaev V.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Beklemishev A.B., Salakhutdinov N.F.
    Bioorganic and Medicinal Chemistry. – 2013. – Vol.21, Issue 21. – P.6690-6698.
    doi: 10.1016/j.bmc.2013.08.014. Epub 2013 Aug 12.
  12. The search for new drugs synthesis and antiviral activity of derivatives of meristotropic and macedonic acids
    Zarubaev V.V., Kiselev O.I.,  Shtro A.A., Zorina A.D., Balykina L.V., Esipenko N.A., Anokhina V.V., Bukkreeva T.V.
    Pharmaceutical Chemistry Journal. – 2013. – Vol.46, № 10. – P.579-583.
    (Original version: Khim.-Pharm.Journ. – 2012. – Vol.46, № 10. – P.3-7.)
  13. Synthesis and biological activity of fullerenols with various contents of hydroxyl groups
    Eropkin M.Y., Bryazzhikova T.S., Eropkina E.M., Danilenko D.M., Kiselev O.I., Melenevskaya E.Y., Nasonova  K.V.
    Pharmaceutical Chemistry Journal. – 2013. – Vol.47, № 2. – P.87-91.
    (Original version: Khim.-Pharm.Journ. – 2013. – Vol.47, № 2. – P.19-23.)
  14. Phylogenetic analysis of six-domain multi-copper blue proteins
    Vasin A.V., Klotchenko S.A., Puchkova L.V.
    PLoS Curr. 2013 Mar 13;5.
  15. Current Methods of Human and Animal Brucellosis Diagnostics
    Smirnova E., Vasin A., Sandybaev N., Klotchenko S., Plotnikova M., Chervyakova O., Sansyzbay A., Kiselev O.
    Advances in Infectious Diseases. – 2013 – V. 3. – N. 3. – P.177-184
  16. A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles
    Blokhina E.A., Kuprianov V.V., Stepanova L.A., Tsybalova L.M., Kiselev O.I., Ravin N.V., Skryabin K.G.*
    Virology. – 2013. – Vol. 435, № 2. – P.293-300.
     doi: 10.16/j.virol.2012.09.014. Epub 2012 Oct 11.
  17. Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector
    Venanzi F., Shifrin V., Sherman M., Gabai V., Kiselev O.,  Komissarov A., Grudinin M., Shartukova M., Romanovskaya-Romanko E.A., Kudryavets Y., Bezdenezhnykh N., Lykhova O., Semesyuk N., Concetti A., Tsyb A., Filimonova M., Makarchuk V., Yakubovsky R., Chursov A., Shcherbinina V., Shneider A.*
    Oncotarget. – 2013. – Vol.4, № 10. – P.1829-1835.

Books and proceedings:

7th Vaccine & ISV ongress 2013, Barcelona, Spain, October 27–29, 2013:

  • Protective properties of inactivated virosomal influenza vaccine
    Erofeeva .., Nickonorov I.J., Maksakova V.L., Stukova M.A., Konshina O.S., Okhapkina E.A., Voicehovskaya E.M., Korovkin S.A., Melnikhov S.J., Kiselev O.I.
  • High specific activity of the vaccine preparation comprising recombinant protein with 4 copies of the influenza virus M2e
    Tsybalova L., Stepanova L., Kupriyanov V., Potapchuk M., Korotkov A., Ravin N.

5th European Congress of Virology, Lyon, France, September, 11–14 2013:

  • Multiplicity of infection determines cell fate in human monolayer cell cultures after influenza A virus infection
    Danilenko D.M., Smirnova T.D., Eropkin M. Yu.
  • Antiviral and cytoprotective activities of fullerenols with the different content of hydroxyl groups
    Eropkin M.Yu., Melenevskay E., Bryazhikova T., Eropkina E., Danilenko D.M.

Options for the control of influenza VIII, Cape Town, South Africa, September 5–10, 2013:

  • Potential Use of Rat Polyclonal Antisera for Antigenic Analysis of Human Influenza Viruses
    Danilenko D.M., Konovalova N.I., Eropkin M. Yu., Smith D.J., Russell C.A.
  • Drug resistance of influenza virus strains circulated in Russia during four epidemic seasons 2009-2010, 2010-2011, 2011-2012 and 2012-2013
    P.M. Anfimov, A.A. Sominina, V.V. Zarubaev, M.P. Grudinin, M.Y. Eropkin, O.I. Kiselev
  • Antiviral activity of usnic acid derivatives against influenza virus in vivo
    A.A. Shtro, O.A. Luzina, M.P. Polovinka, D. N. Sokolov, N. I. Komarova, N. F. Salakhutdinov, O. I. Kiselev, V.V. Zarubaev
  • Novel class of low molecular anti-influenza agents based on camphor pharmacophore
    Zarubaev V.V., Sokolova A.S., Yarovaya O.I., Shernyukov A.V., Tretiak T.S., Anfimov P.M., Kiselev O.I., Salakhutdinov N.F.
  • Molecular genetic characterization of influenza A and B virus strains circulated in Russia in 2010-2013
    Mikhail Grudinin, Anna Kosheleva, Andrey Komissarov, Artem Fadeev, Maria Pisareva, Janna Buzitskaya, Marina Stukova, Oleg Kiselev
  • Main factor of the low antigen content of inactivated H5N1 influenza vaccines – decreased stability of the H5 hemagglutinin protein
    Sergeeva M.V., Krokhin A.A., Tsybalova L.M., Romanova J.R.

“Mechanisms in Biology” 38th Federation of European Biochemical Societies Congress, St. Petersburg, Russia, 6–11 July, 2013:

  • Molecular mechanisms enhancing the coding potential of RNA genome of influenza A viruses
    Vasin A., Temkina O., Klotchenko S., Plotnikova M., Egorov V., Kiselev O.
  • Short peptides which enhance the fibrillogenesis of the model peptide
    Egorov V., Shaldzhyan A., Sirotkin A., Mirgorodskaya O., Vasin A., Lebedev D., Shvetsov A., Grudinina N., Shavlovsky M.
  • Development of multiplex real-time PCR for quantification of cytokines mRNA expression in influenza virus infected human cells
    Plotnikova M., Vasin A.
  • In silico analysis of the conserved regions with stable secondary structure within the NS gene of human influenza A viruses
    Klotchenko S., Brodskaya A., Temkina O., Vasin A.
  • Mechanisms of immunosuppression in viral infections: From retroviruses to Ebola and influenza viruses
    Kiselev O.
  • Thiol-disulfide system as universal biomarker for personalized therapy of infectious diseases and cancer
    Volchek I., Sologub T., Petrov A.

2012

Research papers:

  1. Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009
    Sokolov D. N., Zarubaev V. V., Shtro A. A., Polovinka M. P., Luzina O. A., Salakhutdinov N. F., Kiselev O. I.
    Bioorg Med Chem Lett. – 2012. – V. 22. – .7060-7064
  2. The European Virus Archive: A new source for virology research
    Gould E.A., de Lamballerie X., Goutard B., Eropkin M. et al.
    Antiviral Res. – 2012. – V.95. – N2. – P. 167-171.
  3. Controlled trypsinolysis of human cancer and non-cancer sera for direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
    Toropygin I.Yu., Mirgorodskaya O.A., Moshkovskii S.A., Serebryakova M.V., Archakov A.I.
    International Journal of Mass Spectrometry. – 2012. – V.325-327. – P.121-129
  4. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice
    Tarasov S.A., Zarubaev V.V., Gorbunov E.A., Sergeeva S.A, Epstein O.I.
    Antiviral Res. – 2012. – V.93. – N2. – P. 219-224
  5. Dynamic of Cell Population Structure in Liver Biopsy of the Patients with Chronic Hepatitis Viral Infection
    Tokin I.B., Filimonova G., Tokin I.I., Hussar P.
    Papers on Anthropology. – 2012. – V. XXI. – P. 276-286
  6. New recombinant strain A/HK/Astana/6:2/2010 for prophylaxis of A/H5N1 influenza
    Sultankova K.T., Sandybaev N.T., Chervyakova O.V., Strochkov V.M., Tailakova E.T., Sanayzbay A.R., rynbaev M.B., Gorev N.E., Sergeyeva M.V., Potapchuk M.V., Repko I.A., Tsybalova L.M., Kiselev O.I.
    Biotechnology Research Bulletin. – 2012. – V.1. – P.005-014

Books and proceedings:

  • Virology Textbook
    A.V. Pinevich, A.K. Sirotkin, O.V. Gavrilova, A.A. Potekhin
    St. Petersburg State University, 2012, 432 p.
  • Chronic Viral Hepatitis C: Diagnosis and Clinical Features
    O.P. Dudanova, O.I. Kiselev
    Petrozavodsk, 2012, 80 p.
  • Influenza: Epidemiology, Virology, Prevention and Treatment. Conference for Young Scientists. Collected Papers
    Edited by: L.M. Tsybalova, Dr.Med.Sci, V.V. Egorov, PhD
    St. Petersburg, 2012, 70 p.
  • Influenza: Epidemiology, Virology, Prevention and Treatment. 45th Anniversary Conference Proceedings
    Epub(pdf), 2012, 42 p.
  • Influenza: Epidemiology, Diagnosis, Prevention and Treatment
    Monograph. Edited by: O.I.Kiselev, L.M. Tsybalova, V.I. Pokrovsky
    Moscow, 2012, 496 p.
  • Avian Influenza. The Origin of Biological Disasters. 2nd edition
    edited by V.I. Pokrovsky et al.
    St. Petersburg, 2012, Rostok, 304 p.
  • Influenza and Pregnancy: Combination of Functional and Infectional Immunosuppression
    O.I.Kiselev, V.I. Pokrovsky
    St. Petersburg, 2012, 148 p.
  • Chemo Drugs and Influenza Chemotherapy
    O.I.Kiselev
    St. Petersburg, 2012, Rostok, 272 p.

2011

  1. Influenza: Epidemiology, Prevention and Treatment. Articles and Abstracts
    St. Petersburg, 2011, NP–Print, 72 p. 
  2. Genome of Pandemic Influenza A/H1N1–2009/10 Virus.
    O.I.Kiselev
    St. Petersburg–Moscow, 2011, Dimitrade Graphic Grougp, 164 p.
  3. Topical Problems of Socially Significant Viral Infections. Materials of the 10th Anniversary Russian–Italian Conference
    Edited by O.I.Kiselev, DrBiolSci., G.S. Arkhipov, DrMedSci., E.I. Arkhipova, DrMedSci.
    Velikiy Novgorod, 2011, ZAO «Novgorodskiy Technopark», 172 p.
  4. Guidelines for Virus Isolation, Influenza IFA and PCR Diagnosis and Submitting Sentinel Surveillance Data Online
    St. Petersburg, 2011, 68 p.
  5. Isolation, antigenic analysis and biological properties of pandemic influenza viruses A(H1N1)v circulated in Russian Federation in the epidemic season 2009-2010
    Eropkin M.U., Danilenko D.M., Konovalova N.I., Grigorieva V.A., Ivanova A.I., Gudkova T.M., Grigorieva V.A., Smirnova T.S.
    Turkish Journal of Clinical Laboratory. – 2011. – Vol. 2, № 1. – P. 27-33.
  6. Differential cell culture susceptibility and proliferative response to avian, human, and swine influenza viruses
    Danilenko D.M., Smirnova T.D., Gudkova T.M., Eropkin M.Yu., Kiselev O.I.
    Influenza and Other Respiratory Viruses. – 2011. - Vol. 5, Suppl. 1. – P. 54-59.
  7. Pandemic influenza in Russia: detection and molecular characterization of the H1N1v virus
    Grudinin M., Komissarov A., Pisareva M., Stukova M., Buzitskaya J., Elpaeva E., Slita A., Romanovskaya-Romanko E., Azarenok A., Prochukhanova A., Kiselev O.
    Influenza and Other Respiratory Viruses. – 2011. – Vol. 5, Suppl. 1. – P. 395-397.
  8. Pandemic influenza 2009 in Russia: isolation, antigenic analysis, and biological properties of viruses
    Eropkin M.Y., Danilenko D.M., Konovalova N.I., Ivanova A.V., Gudkova T.M., Grigorieva V.A.
    Influenza and Other Respiratory Viruses. – 2011. – Vol. 5, Suppl. 1. – P. 416-418.
  9. Comparison of influenza outbreaks in the Republic of Kazakhstan and Russia induced by 2009 yearly new variant of (H1N1) influenza virus
    Karpova L.S., Popovtseva N.M., Stolyarova T.P., Stolyarov K.A., Mamadaliyev S.M., Khairullin B.M., Sandybayev N.T., Kydyrbayev Zh.K., Orynbayev M.B., Ospanov K.S., Baiserkin B.S., Boibosinov E.U.
    Virologica Sinica. – 2011. – Vol.26, № 5. – P. 306-314.
  10. Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture
    Roethl E., Gassner M., Krenn B.M., Romanovskaya-Romanko E.A., Seper H., Romanova J., Nakowitsch S., Sturlan S., Wolschek M., Sirotkin A., Kiselev O., Muster T., Egorov A.
    Journal of Virology. – 2011. – Vol. 85, № 21. – P. 11139-11145.
  11. Modeling of self-organization of two-dimensional ordered structures
    Egorov V.V., Garmay Y.P., Shaldzhyan A.A., Lebedev D.V., Vasin A.V., Grudinina N.A., Kiselev O.I.
    Journal of Physics: Conference Series. – 2011. – Vol. 291, № 1, 012005. DOI: 10.1088/1742-6596/291/1/012005
  12. Multisegment one-step RT-PCR fluorescent labeling of influenza A virus genome for use in diagnostic microarray application
    Vasin A.V., Sandybaev N.T., Plotnikova M.A., Klotchenko S.A., Chervyakova O.V. Strochkov V.M., Taylakova E.T., Elpaeva E.A., Komissarov A.B., Egorov V.V., Koshemetov J.K., Kiselev O.I., Mamadaliev S.M.
    Journal of Physics: Conference Series. – 2011. – Vol. 291, № 1, 012006. DOI: 10.1088/1742-6596/291/1/012006
  13. Expression in E. coli and purification of the fibrillogenic fusion proteins TTR-sfGFP and β2M-sfGFP
    Solovyov K.V., Polyakov D.S., Grudinina N.A., Egorov V.V., Morozova I.V., Aleynikova T.D., Shavlovsky M.M.
    Preparative Biochemistry and Biotechnology. – 2011. – Vol. 41, № 4. – P.337-349.
  14. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1
    Krenn B.M., Egorov A., Romanovskaya-Romanko E., Wolschek M., Nakowitsch S., Ruthsatz T., Kiefmann B., Morokutti A., Humer J., Geiler J., Cinatl J., Wressnigg N., Sturlan S., Ferko B., Batishev O.V., Indenbom A.V., Zhu R ., Kastner M ., Hinterdorfer P., Kiselev O., Muster T., Romanova J.
    PLoS One. – 2011. – Vol. 6, № 4, e 18577. DOI: 10.1371/journal.pone.0018577
  15. Antiviral activity of 3-methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol and its derivatives against influenza A(H1N1)2009 virus
    Ardashov O.V., Zarubaev V.V., Shtro A.A., Korchagina D.V., Volcho K.P., Salakhutdinov N.F., Kiselev O.I.
    Letters in Drug Design & Discovery. – 2011. – Vol. 8, № 4. – p. 375-380.
  16. Dependence of biological effects of fullerene C60 in vitro from the type of preparations
    Piotrovsky L.B., Dumpis M.A., Litasova E.V., Eropkin M.Yu., Eropkina E.M., Kiselev O.I.
    Fullerenes, Nanotubes and Carbon Nanostructures. – 2011. – Vol. 19, № 1. – P. 147-153.
  17. Birch bark extract as therapy for chronic hepatitis C – A pilot study
    Shikov A. N., Djachuk G. I., Sergeev D. V., Pozharitskaya O. N., Esaulenko E. V., Kosman V. M., Makarov V. G.
    Phytomedicine. – 2011. – Vol.18, № 10. – P.807-810.

2010

  1. Influenza Pandemic 2009/2010: Antiviral Therapy and Treatment Schemes
    O.I. Kiselev ,F.I. Ershov, A.T. Bykov, V.I. Pokrovsky
    2010, A–Print, 100 p.
  2. «Antiviral properties, Metabolism, and Pharmacokinetics of a Novel Azolo-1,2,4-Triazine-Derived Inhibitor of Influenza A and B virus replication»
    Karpenko I., Deev S., Kiselev O., Charushin V., Rusinov V., Ulomsky E., Deeva E., Yanvarev D., Ivanov A., Smirnova O., Kochetkov S., Chupakhin O, .Kukhanova M.
    Antimicrobial Agents and Chemotherapy - 2010. –V. 54. # 5 – P. 2017-2022
  3. «Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus»
    Zarubaev V. V., Golod E. L., Anfimov P. M., Shtro A. A., Saraev V. V., Gavrilov A. S., Logvinov A. V., Kiselev O. I.
    Bioorg. Med. Chem. 2010, V. 18 – P.839-848.
  4. «Determination of total aminothiols and neuroactive aminoacids in plasma by high performance liquid chromatography with fluorescence detection»
    Pozdeev V. K., Pozdeyev N. V.
    Biochemistry (Moscow) supplement series B: Boimedical chemistry. -2010. – V. 4, № 3 - .288-295.
  5. «Mass spectrometry and biochemical analysis of RNA polymerase II: targeting by protein phosphatase-1»
    Jerebtsova M., Klotchenko S., Artamonova T., Ammosova T., Washington K., Egorov V., Shaldzhyan A., Sergeeva M., Zatulovskiy E., Temkina O., Petukhov M., Vasin A., Khodorkovskii M., Orlov Yu., Nekhai S.
    Mol Cell Biochem DOI 10.1007/s11010-010-0614-3 Published online: 13 October 2010.

2009

  1. «Development of a live-attenuated influenza B DelNS1 intranasal vaccine candidate»
    N. Wressnigg, D. Voss, T. Wolff, J. Romanova, T. Ruthsatz, I. Mayerhofer, M. Reiter, S. Nakowitsch, J. Humer, A. Morokutti, T. Muster, A. Egorov, C. Kittel
    Vaccine. – 2009. – Vol.27, № 21. – P.2851-2857
  2. «Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice»
    N. Wressnigg, A.-P. Shurygina, T. Wolff, M. Redlberger-Fritz, T. Popow-Kraupp, T. Muster, A. Egorov, C. Kittel
    J. Gen. Virology. –2009. Vol. 90, pt. 2. – P. 366-374